Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 12/22/2014 11:55:41 AM - Followers: 532 - Board type: Free - Posts Today: 145

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Notice of Effectiveness (effect) 11/19/2014 06:01:25 AM
CTIX News: Securities Registration Statement (simplified Form) (s-3/a) 11/10/2014 05:31:51 PM
CTIX News: Securities Registration Statement (simplified Form) (s-3) 10/30/2014 04:31:15 PM
CTIX News: Current Report Filing (8-k) 10/24/2014 06:04:28 AM
CTIX News: ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK 10/14/2014 06:00:00 AM
PostSubject
#83573  Sticky Note Cellceutix Reports Positive Results of Brilacidin in Microbiological BooDog 12/22/14 07:29:44 AM
#82182  Sticky Note Cellceutix’s Prurisol: A Potential Blockbuster Psoriasis Treatment TOB 12/12/14 02:57:09 PM
#82180  Sticky Note $CTIX Lead drug info, News, SEC filings, FDA KarinCA 12/12/14 02:53:03 PM
#81271  Sticky Note Cellceutix may achieve a second valuable QIDP designation TOB 12/09/14 12:46:14 PM
#80645  Sticky Note Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA starbuxsux 12/08/14 09:08:42 AM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#83702   Daydreaming - After rereading the PR for the Astavakra 12/22/14 11:55:41 AM
#83701   Kelt, this is my view as well. BioHedge 12/22/14 11:54:30 AM
#83700   Scheduling in December is often problematic, especially with thefamilyman 12/22/14 11:51:17 AM
#83699   The PR was needed as a follow up Amatuer17 12/22/14 11:50:15 AM
#83698   I'm not sure what the details from the BioHedge 12/22/14 11:49:40 AM
#83697   I agree with everything you said here. TheMonolith 12/22/14 11:49:39 AM
#83696   I agree that nothing is simple in biotech. KarinCA 12/22/14 11:47:28 AM
#83695   I think there is more going on than keltoi 12/22/14 11:41:27 AM
#83694   Karin, the go ahead for P was a Rdunn88 12/22/14 11:39:59 AM
#83693   I think that the FDA surprised them with thefamilyman 12/22/14 11:39:55 AM
#83692   I'm thinking the FDA was given some concrete KarinCA 12/22/14 11:35:08 AM
#83691   Good morning BH, glad to see you on. daydreaming2 12/22/14 11:30:33 AM
#83690   BioHedge, 100 agree!!! Also, the CEO should separate Rdunn88 12/22/14 11:25:03 AM
#83689   Couldn't agree more. I've been saying that from faraifarai 12/22/14 11:19:53 AM
#83688   Looks like a test to the 3's again. Rdunn88 12/22/14 11:15:35 AM
#83687   Out of whack expectations. Leo's life blood for BioHedge 12/22/14 11:12:28 AM
#83686   There were several laundry lists of potential PRs Ebuilder 12/22/14 11:11:10 AM
#83685   Does it now seem like that is it Ovidius 12/22/14 11:08:19 AM
#83684   No I won't sell at $10, to me tombrady12nh 12/22/14 11:03:25 AM
#83683   IRB approval is an important step toward the sox040713 12/22/14 11:00:19 AM
#83682   Great PR this morning but it's making a Looping 12/22/14 10:59:30 AM
#83681   MD Anderson, Dana Farber, Beth Israel, FDA QIDP rule_rationale 12/22/14 10:57:33 AM
#83680   Exactly right. Why spend tens of thousands robwilly 12/22/14 10:55:16 AM
#83679   Exactly why today's PR was not needed. 12/22/14 Rdunn88 12/22/14 10:53:07 AM
#83678   Do you think he owns CTIX? I F1ash 12/22/14 10:50:46 AM
#83677   I don't think the buying opportunity is gone TheHound 12/22/14 10:47:38 AM
#83676   maz, with all due respect, you have been 58nout 12/22/14 10:41:37 AM
#83675   Sounds like the delay is in no way oddone33320 12/22/14 10:41:24 AM
#83674   Exactly what my wife keeps telling me. BooDog 12/22/14 10:38:21 AM
#83673   The problem is CTIX is not "beyond" releases maz100577 12/22/14 10:37:43 AM
#83672   Concur. Smarter to give no news and let faraifarai 12/22/14 10:32:45 AM
#83671   If the antiobiotic space is a code red faraifarai 12/22/14 10:27:58 AM
#83670   Well comedy, amateur hour, is about over. Share Citrati 12/22/14 10:27:30 AM
#83669   Would have preferred word better rather than similar, faraifarai 12/22/14 10:24:01 AM
#83668   I am trying to understand, is $10 a F1ash 12/22/14 10:23:55 AM
#83667   Sure, we can all go back and re-look TheDane 12/22/14 10:22:29 AM
#83666   another look at the Chart.... 123tom 12/22/14 10:17:36 AM
#83665   I see we hit $4.01 (not that I TheDane 12/22/14 10:16:20 AM
#83664   Wow, thought I was on the CTIX board TheDane 12/22/14 10:12:26 AM
#83663   Anyone who says they don't care about the TheDane 12/22/14 10:11:17 AM
#83662   EDIT: That buying opportunity came and went noretreat 12/22/14 10:10:57 AM
#83661   Used this dip to add more just don't dgjared 12/22/14 10:05:43 AM
#83660   Thanks for sharing with the group Wildman. Hopefully scgmck1 12/22/14 10:05:39 AM
#83659   Leo should have saved that PR for the tombrady12nh 12/22/14 10:05:07 AM
#83658   Hopefully you got in while the sale was Chester0711 12/22/14 10:00:09 AM
#83657   Someone with cash just loaded up.....weak hands .lol Vlady 1 12/22/14 09:59:30 AM
#83656   I thought you said there was s--g 1400 12/22/14 09:56:24 AM
#83655   I'd say... Where to buy?? How much is TheHound 12/22/14 09:53:51 AM
#83654   whoa ... buying opportunity coming up noretreat 12/22/14 09:48:51 AM
#83653   Dreaming of higher prices on PK data. You TheHound 12/22/14 09:48:02 AM
PostSubject